Kathmandu: Corona virus infection has been confirmed in 2,768 people in the last 24 hours.



According to the Ministry of Health and Population, among 7,569 PCR test 1,963 tested positive and among 5,468 antigen tests virus has been confirmed on 2,568 people.



In the last 24 hours, 44 people have died and 4,020 have been recovered from the corona.

Another 2,768 infected with corona, 44 dies

Kathmandu: Corona virus infection has been confirmed in 2,607 people in the last 24 hours.



According to the Ministry of Health and Population, the PCR test on 7,711 people confirmed the infection in 1,768 people and the antigen test in 4,773 people confirmed the infection in 839 people.



Meanwhile, in the last 24 hours, 39 people have died and 2,141 people have been cured of the corona.

2607 infected, 39 died from corona in last 24 hours

Kathmandu: In the last 24 hours, an additional 2,745 people have been confirmed infected with the corona virus.



According to the Ministry of Health and Population, out of 7,449 PCR tests 1,681 tested positive and out of 5,841 antigen tests 1,064 tested positive for coronavirus.



In the last 24 hours, 41 people have died due to the infection while 4,187 infected people have been cured of corona infection.

2,745 people infected; 4,187 recovered from corona in last 24 hours

AP: Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico, potentially offering the world yet another weapon against the virus at a time when developing countries are desperate for doses.



The two-shot vaccine was about 90 percent effective overall, and preliminary data showed it was safe, the American company said. That would put the vaccine about on par with Pfizer’s and Moderna’s.



While demand for COVID-19 shots in the U.S. has dropped off dramatically and the country has more than enough doses to go around, the need for more vaccines around the world remains critical. The Novavax vaccine, which is easy to store and transport, is expected to play an important role in boosting supplies in poor parts of the world.



That help is still months away, however. The company, which has been plagued by raw-material shortages that have hampered production, said it plans to seek authorization for the shots in the U.S., Europe and elsewhere by the end of September and will be able to produce up to 100 million doses a month by then.



“Many of our first doses will go to … low- and middle-income countries, and that was the goal to begin with,” Novavax CEO Stanley Erck said.



While more than half of the U.S. population has had at least one vaccine dose, less than one percent of people in the developing world have had one shot, according to a data collection effort run in part by the University of Oxford.



The Novavax shot stands to become the fifth Western-developed COVID-19 vaccine to win clearance. The Pfizer, Moderna and Johnson &amp; Johnson vaccines are already authorized for use in the U.S. and Europe. Europe also uses AstraZeneca’s formula.



Novavax’s study involved nearly 30,000 people ages 18 and up. Two-thirds received two doses of the vaccine, three weeks apart, and the rest got dummy shots. Nearly half the volunteers were Black, Hispanic, Asian American or Native American, and 6% of participants were in Mexico. Altogether, 37% had health problems that made them high risk, and 13% were 65 or older.



There were 77 cases of COVID-19 — 14 in the group that got the vaccine, the rest in volunteers who received the dummy shots. None in the vaccine group had moderate or severe disease, compared with 14 in the placebo group. One person in that group died.



The vaccine was similarly effective against several variants, including the one first detected in Britain that is now dominant in the U.S., and in high-risk populations, including the elderly, people with other health problems and front-line workers in hospitals and meatpacking plants.



“These consistent results provide much confidence in the use of this vaccine for the global population,” said Dr. Paul Heath, director of the Vaccine Institute at the University of London and St. George’s Hospital.



Side effects were mostly mild — tenderness and pain at the injection site. There were no reports of unusual blood clots or heart problems, Erck said.



A study underway in Britain is testing which of several vaccines, including Novavax’s, works best as a booster shot for people who received the Pfizer or AstraZeneca formula. Industry analyst Kelechi Chikere said the Novavax shot could become a “universal booster” because of its high effectiveness and mild side effects.



Novavax reported the results in a news release and plans to publish them in a medical journal, where they will be vetted by independent experts. The Gaithersburg, Maryland-based company previously released findings from smaller studies in Britain and South Africa.



COVID-19 vaccines train the body to recognize the coronavirus, especially the spike protein that coats it, and get ready to fight the virus off. The Novavax vaccine is made with lab-grown copies of that protein. That’s different from some of the other vaccines now widely used, which include genetic instructions for the body to make its own spike protein.



The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute.



As for the shortages that delayed manufacturing, Erck said those were due to restrictions on shipments from other countries.



“That’s opening up,” he said, adding that Novavax now has weeks’ worth of needed materials in its factories, up from just one week.



The company has committed to supplying 110 million doses to the U.S. over the next year and a total of 1.1 billion doses to developing countries.



In May, vaccines alliance Gavi, a leader of the U.N.-backed COVAX project to supply shots to poorer countries, announced it signed an agreement to buy 350 million doses of Novavax’s formula. COVAX is facing a critical shortage of vaccines after its biggest supplier in India suspended exports until the end of the year.



Novavax has been working on developing vaccines for more than three decades but hasn’t brought one to market. Its coronavirus vaccine work is partly funded by the U.S. government.



Dr. Peter English, a vaccine expert previously with the British Medical Association, called the Novavax results “excellent news.” English said that because vaccine production is complicated, it’s crucial to have as many shots as possible.



“Any minor imperfection in the production plant can shut down the production for days or weeks,” he said in a statement. “The more different manufacturers we have producing vaccine, the more likely it is we will have availability of vaccines.”



He said it was also encouraging news that Novavax would be able to adapt its vaccine to any potentially worrying variants in the future if necessary.

Novavax: Large study finds COVID-19 shot about 90pc effective

Kathmandu: Corona virus infection has been confirmed in 2,407 people in the last 24 hours.



According to the Ministry of Health and Population, corona virus infection has been confirmed in 2,407 people, including 1,694 through PCR and 713 through antigen.



In the last 24 hours, 46 people have died from corona infection, according to the ministry. An additional 3,994 people have been recovered.

Another 2,407 infected, 46 died

Kathmandu: In the last 24 hours, 6,295 corona infections have been recovered from corona infection. Similarly, corona virus (Covid-19) infection has been confirmed in an additional 3,384 people across the country.



A total of 14,494 samples tested including 8,506 samples for PCR and 5,988 samples for antigen. Of which 2,382 PCR samples while 1,082 antigen samples tested positive.



According to the Ministry of Health and Population, another 61 people have died from the corona infection. The total number of corona infections in Nepal has now reached 606,778. Out of which 8,366 people have died and 527,111 people have been cured so far.



Currently, the number of actively infected people in the country is 71,301. Of them, 65,953 are in home isolation and 5,348 are in institutional isolation. Of them, 1,206 are undergoing treatment in ICU and 373 in a ventilator.

61 died while 6,295 recovered from corona

Ranja (Rashtriya Samachar Samiti): Preparations for the third wave have begun in Banke, which has become a 'hotspot' at the beginning of the first and second waves of the COVID-19 pandemic.



The locals of Banke are preparing for the prevention and response of the third wave of corona virus outbreak. Khajura rural municipality Chairman Kismat Kumar Kaksapati informed that necessary preparations have been started as the third wave of epidemic could spread again even if the corona virus infection and death rate are decreasing recently.



He said that the homework has already been started to prevent the possible effect of third wave of COVID-19. He said that preparations have been started for the control and response of the third wave of Corona epidemic.



The Nepalgunj sub-metropolitan city is planning to plan prevention and mitigation programs by targeting the corona virus infection in the coming fiscal year. Sub-metropolitan spokesperson Pramod Rijal said that necessary preparations have been made for that by coordinating with the province, central government and health organizations.



Shiva Ram Gelal, coordinator and chief district officer of District Covid-19 Crisis Management Center Banke, said that they will move ahead by formulating necessary strategies at the district level to combat the third wave of corona epidemic.



He informed that as Banke is a border district of India, people movement will be halting, health check-ups will be increasing and necessary works will be done with preparation and planning in coordination with the local levels.

Preparations against third wave of COVID-19 underway in Banke

CARBIS BAY, England (AP): World leaders from the Group of Seven industrialized nations are set to commit at their summit to share at least 1 billion coronavirus shots with struggling countries around the world — half the doses coming from the U.S. and 100 million from the U.K.



Vaccine sharing commitments from President Joe Biden and British Prime Minister Boris Johnson set the stage for the G-7 leaders’ meeting in southwest England, where leaders will pivot Friday from opening greetings and a “family photo” directly into a session on “Building Back Better From COVID-19.”



“We’re going to help lead the world out of this pandemic working alongside our global partners,” Biden said, adding that the G-7 nations would join the U.S. in outlining their vaccine donation commitments at the three-day summit. The G-7 also includes Canada, France, Germany, Italy and Japan.



The leaders meeting in the resort of Carbis Bay hope to energize the global economy as well. On Friday they are set to formally embrace a global minimum tax of at least 15% on corporations, seconding an agreement reached a week ago at a meeting of their finance ministers. The minimum is meant to stop companies from using tax havens and other tools to avoid taxes.



It represents a potential win for the Biden administration, which has proposed a global minimum tax as a way to pay for infrastructure projects, in addition to creating an alternative that could remove some European countries’ digital services taxes that largely hit U.S. tech firms.



For Johnson, the first G-7 summit in two years — last year’s was scuttled by the pandemic — is a chance to set out his vision of a post-Brexit “Global Britain” as a midsized country with an outsized role in international problem-solving.



It’s also an opportunity to underscore the U.K-U.S. bond, an alliance often called the “special relationship.”



After a meeting with Biden that both sides hailed as a success, Johnson said he prefers the term “indestructible relationship.”



The official summit business starts Friday, with the customary formal greeting and a socially distanced group photo. Later the leaders will meet Queen Elizabeth II and other senior royals at the Eden Project, a lush, domed eco-tourism site built in a former quarry pit



The G-7 leaders have faced mounting pressure to outline their global vaccine-sharing plans, especially as inequities in supply around the world have become more pronounced. In the U.S., there is a large vaccine stockpile and the demand for shots has dropped precipitously in recent weeks.



Biden said the U.S. will donate 500 million COVID-19 vaccine doses and previewed a coordinated effort by the advanced economies to make vaccination widely and speedily available everywhere. The commitment was on top of 80 million doses Biden has already pledged to donate by the end of June.



Johnson, for his part, said the first 5 million U.K. doses would be shared in the coming weeks, with the remainder coming over the next year. He said he expected the G-7 to commit to 1 billion doses in all.



“At the G-7 Summit I hope my fellow leaders will make similar pledges so that, together, we can vaccinate the world by the end of next year and build back better from coronavirus,” Johnson said in a statement, referencing a slogan that he and Biden have both used.



French President Emmanuel Macron welcomed the U.S. commitment and said Europe should do the same. He said France would share at least 30 million doses globally by year’s end.



At a news conference, he said time was of the essence.



“It’s almost more important to say how many (doses) we deliver the next month than making promises to be fulfilled in 18 months from now,” he said.



Biden predicted the U.S. doses and the overall G-7 commitment would “supercharge” the global vaccination campaign, adding that the U.S. doses come with no strings attached.



“Our vaccine donations don’t include pressure for favors or potential concessions,” Biden said. “We’re doing this to save lives, to end this pandemic, that’s it.”



He added: “Our values call on us to do everything that we can to vaccinate the world against COVID-19.″



The U.S. commitment is to buy and donate 500 million Pfizer doses for distribution through the global COVAX alliance to 92 lower-income countries and the African Union, bringing the first steady supply of mRNA vaccine to the countries that need it most.



The Pfizer agreement came together with some urgency in the last four weeks at Biden’s direction, said a senior White House official, both to meet critical needs overseas and to be ready for announcement at the G-7. The official, who spoke on condition of anonymity to discuss internal plans, added that the Biden administration was to apply the same wartime posture applied to the vaccine rollout in the U.S. to its effort to share vaccines globally.



Biden said the 500 million U.S.-manufactured vaccines will be shipped starting in August, with the goal of distributing 200 million by the end of the year. The remaining 300 million doses would be shipped in the first half of 2022. A price tag for the doses was not released, but the U.S. is now set to be COVAX’s largest vaccine donor in addition to its single largest funder with a $4 billion commitment.



The well-funded global alliance has faced a slow start to its vaccination campaign, as richer nations have locked up billions of doses through contracts directly with drug manufacturers. Biden’s move, officials said, was meant to ensure a substantial amount of manufacturing capacity remains open to the wealthy nations. Just last month, the European Commission signed an agreement to purchase as many as 1.8 billion Pfizer doses in the next two years, a significant share of the company’s upcoming production — though the bloc reserved the right to donate some of its doses to COVAX.



COVAX has distributed just 81 million doses globally and parts of the world, particularly in Africa, remain vaccine deserts.



White House officials said the ramped-up distribution program fits a theme Biden plans to hit frequently during his week in Europe: that Western democracies, and not authoritarian states, can deliver the most good for the world.



Biden, in his remarks, harked back to the Detroit-area workers who 80 years ago built tanks and planes “that helped defeat the threat of global fascism in World War II.”



“They built what became known as the arsenal of democracy,” Biden said. “Now a new generation of American men and women, working with today’s latest technology, is going to build a new arsenal to defeat the current enemy of world peace, health and stability: COVID-19.”



China and Russia have shared their domestically produced vaccines with some needy countries, often with hidden strings attached. Sullivan said Biden “does want to show — rallying the rest of the world’s democracies — that democracies are the countries that can best deliver solutions for people everywhere.”

G-7 nations gather to pledge 1B vaccine doses for world

Kathmandu: In the last 24 hours, an additional 3,749 people have been confirmed infected with the corona virus. According to the Ministry of Health and Population, the PCR test of 9,901 samples tested positive for 2,874 people and the antigen test for 5,337 people tested positive for 875 people.



At the same time, the total number of people infected with the corona virus in Nepal has reached 619,401. Out of which 515,591 people have been recovered and 77,858 people are actively infected.



Meanwhile, corona infections have killed 59 people in the last 24 hours. So far, the death toll has reached 8,238. In the last 24 hours, 5,293 people have been recovered, the ministry said.

3,749 people infected, 59 died of corona

Kathmandu: The vaccination campaign against covid-19 infection in Kathmandu Metropolitan City (KMC) has been halted in lack of vaccines.



According to KMC vaccination program had to be postponed due to the government's inability to provide enough vaccines.



The Kathmandu Metropolitan City (KMC) had launched a campaign to give Chinese vaccine (Verosell) to senior citizens in the age group of 60-64 years from June 9 onwards. However, the metropolis said it had to suspend the campaign until further notice due to insufficient vaccines.



KMC has given the first dose of vaccine to 28,000 senior citizens in the age group of 60-64 years in a period of three days. As per KMC, the District Public Health Office has provided 32,000 vaccines to Kathmandu Metropolitan City, and 28,000 have been used in three days. The remaining 4,000 vaccines have been postponed until the government provides more vaccines.

Vaccination against covid infection halts in Kathmandu valley

Kathmandu: The Ministry of Health has written a letter to the Ministry of Industry, Commerce and Supplies to monitor hospitals and take action against those who have been charged more than prescribed for corona treatment.



According to a letter sent to Commerce Ministry by the Health Emergency Operations Center under the Ministry of Health and Population, the decision has been taken at a ministerial decision on Tuesday.



The government has set a daily limit of Rs 3,500 for general covid patients, Rs 7,000 for moderate and Rs 15,000 for critically ill patients.



The Ministry of Health has also asked Commerce Ministry to monitor all government hospitals and hospitals that have been made public to provide services through service agreements with the Ministry of Health.

Health Ministry's direction to inspect covid hospital fees

Kathmandu: In the last 24 hours, 5,153 people have been confirmed to be infected with the corona virus.



Out of 12,065 PCR tests 3,870 and out of 5,611 antigen tests, 1,283 people have been tested positive.



According to the Ministry of Health and Population, 108 people have died and 6,570 have been recovered from corona infection.



At the same time, the total number of corona infections in Nepal has reached 611,308. Out of which 545,030 have been cured. The number of active infected people in the country is 82,736.



The corona virus has killed 8,098 people so far.

Corona

Our Team

Contact Information

Address (USA):

Address (Nepal):

Email:

Phone: